TrialDiabetes, obesity & metabolism2019

Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trial.

Megumi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.